Literature DB >> 21922391

Immunoglobulin G4-related lymphadenopathy with inflammatory pseudotumor-like features.

Yasuharu Sato1, Masaru Kojima, Katsuyoshi Takata, Xingang Huang, Eiko Hayashi, Akihiro Manabe, Yukari Miki, Tadashi Yoshino.   

Abstract

Immunoglobulin (Ig) G4-related disease has been recently described. This disease affects various organs, including lymph nodes. We describe the case of a 52-year-old Japanese man with IgG4-related lymphadenopathy with inflammatory pseudotumor (IPT)-like features. Five years ago, the patient noticed a painless mass in the mandible but did not consult a doctor. Recently, he noted that the mass had increased in size and consulted an oral surgeon in the hospital. Excisional biopsy was performed for diagnosis. Histopathological examination revealed that most of the enlarged lymph node was occupied by the hyalinized tissue. A few residual lymphoid follicles with hyperplastic germinal centers and infiltration of plasma cells and eosinophils were observed. Most of the plasma cells expressed IgG4, and the ratio of IgG4-positive cells to IgG-positive cells was 57.1%. These findings were consistent with IgG4-related lymphadenopathy. In conclusion, pathologists should consider IgG4-related lymphadenopathy when diagnosing a lesion with IPT-like features.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922391     DOI: 10.1007/s00795-010-0525-0

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  12 in total

1.  Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.

Authors:  Y Masaki; L Dong; N Kurose; K Kitagawa; Y Morikawa; M Yamamoto; H Takahashi; Y Shinomura; K Imai; T Saeki; A Azumi; S Nakada; E Sugiyama; S Matsui; T Origuchi; S Nishiyama; I Nishimori; T Nojima; K Yamada; M Kawano; Y Zen; M Kaneko; K Miyazaki; K Tsubota; K Eguchi; K Tomoda; T Sawaki; T Kawanami; M Tanaka; T Fukushima; S Sugai; H Umehara
Journal:  Ann Rheum Dis       Date:  2008-08-13       Impact factor: 19.103

2.  Inflammatory pseudotumor of lymph nodes: a study of 25 cases with emphasis on morphological heterogeneity.

Authors:  C A Moran; S Suster; S L Abbondanzo
Journal:  Hum Pathol       Date:  1997-03       Impact factor: 3.466

3.  Chronic sclerosing pyelitis with an increased number of IgG4-positive plasma cells.

Authors:  Naoto Kuroda; Shoichiro Nakamura; Katsushi Miyazaki; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Yasuharu Sato; Tadashi Yoshino
Journal:  Med Mol Morphol       Date:  2009-12-24       Impact factor: 2.309

4.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 5.  IgG4-related disease: historical overview and pathology of hematological disorders.

Authors:  Yasuharu Sato; Kenji Notohara; Masaru Kojima; Katsuyoshi Takata; Yasufumi Masaki; Tadashi Yoshino
Journal:  Pathol Int       Date:  2010-04       Impact factor: 2.534

6.  Inflammatory pseudotumor of lymph nodes: clinicopathologic and immunohistological study of 11 Japanese cases.

Authors:  M Kojima; S Nakamura; K Shimizu; Y Hosomura; Y Ohno; H Itoh; N Yamane; K Yoshida; N Masawa
Journal:  Int J Surg Pathol       Date:  2001-07       Impact factor: 1.271

7.  Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis.

Authors:  Hideaki Hamano; Shigeyuki Kawa; Yasuhide Ochi; Hiroshi Unno; Nobuhiko Shiba; Masahisa Wajiki; Koh Nakazawa; Hisashi Shimojo; Kendo Kiyosawa
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

8.  Ocular adnexal IgG4-related disease has uniform clinicopathology.

Authors:  Yasuharu Sato; Koh-ichi Ohshima; Kouichi Ichimura; Masakazu Sato; Ichiro Yamadori; Takehiro Tanaka; Katsuyoshi Takata; Toshiaki Morito; Eisaku Kondo; Tadashi Yoshino
Journal:  Pathol Int       Date:  2008-08       Impact factor: 2.534

9.  Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis.

Authors:  Yoh Zen; Takahiko Fujii; Kenichi Harada; Mitsuhiro Kawano; Kazunori Yamada; Masayuki Takahira; Yasuni Nakanuma
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

10.  Splenic inflammatory pseudotumor (inflammatory myofibroblastic tumor).

Authors:  Hisashi Oshiro; Masato Nomura; Shoji Yamanaka; Shinichiro Watanabe; Yoshiaki Inayama
Journal:  J Clin Exp Hematop       Date:  2007-11
View more
  6 in total

1.  Inflammatory Myofibroblastic Tumor of the Nasal Cavity.

Authors:  Rachel L Werner; James T Castle
Journal:  Head Neck Pathol       Date:  2015-10-19

Review 2.  Inflammatory myofibroblastic tumors of the nasal cavity and paranasal sinus: a clinicopathologic study of 25 cases and review of the literature.

Authors:  Chun-Yan He; Ge-Hong Dong; Dong-Mei Yang; Hong-Gang Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-23       Impact factor: 2.503

3.  IgG4-Related Lymphadenopathy.

Authors:  Yasuharu Sato; Tadashi Yoshino
Journal:  Int J Rheumatol       Date:  2012-06-10

4.  Systemic IgG4-related disease with extensive peripheral nerve involvement that progressed from localized IgG4-related lymphadenopathy: an autopsy case.

Authors:  Masayoshi Fujii; Yasuharu Sato; Nobuya Ohara; Kenji Hashimoto; Haruhiko Kobashi; Yoshinobu Koyama; Tadashi Yoshino
Journal:  Diagn Pathol       Date:  2014-02-21       Impact factor: 2.644

5.  Unexpected eosinophilia in children affected by hydrocephalus accompanied with shunt infection.

Authors:  Bartosz Polis; Lech Polis; Krzysztof Zeman; Jarosław Paśnik; Emilia Nowosławska
Journal:  Childs Nerv Syst       Date:  2018-07-21       Impact factor: 1.475

6.  A case of inflammatory pseudotumour of the gallbladder presenting as a big mass of uncertain behavior.

Authors:  Antonio Calvo; Jesús Salas; Gloria Muñoz; Ana Díez; María Coral de la Vega
Journal:  BMC Gastroenterol       Date:  2020-08-24       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.